Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cancer immunotherapy: in vivo imaging of adoptively transferred T cells in an immunocompetent host.

Literature DB >> 20671198

Cancer immunotherapy: in vivo imaging of adoptively transferred T cells in an immunocompetent host.

Padmanee Sharma¹.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2010 PMID： 20671198 PMCID： PMC2922614 DOI： 10.1073/pnas.1009415107

Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN： 0027-8424 Impact factor: 11.205

× No keyword cloud information.

19 in total

1. Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells.

Authors: C Yee; J A Thompson; D Byrd; S R Riddell; P Roche; E Celis; P D Greenberg
Journal: Proc Natl Acad Sci U S A Date: 2002-11-11 Impact factor: 11.205

2. Transfer of specificity for human immunodeficiency virus type 1 into primary human T lymphocytes by introduction of T-cell receptor genes.

Authors: L J Cooper; M Kalos; D A Lewinsohn; S R Riddell; P D Greenberg
Journal: J Virol Date: 2000-09 Impact factor: 5.103

3. Transfer of specificity by murine alpha and beta T-cell receptor genes.

Authors: Z Dembić; W Haas; S Weiss; J McCubrey; H Kiefer; H von Boehmer; M Steinmetz
Journal: Nature Date: 1986 Mar 20-26 Impact factor: 49.962

4. Efficient transfer of a tumor antigen-reactive TCR to human peripheral blood lymphocytes confers anti-tumor reactivity.

Authors: T M Clay; M C Custer; J Sachs; P Hwu; S A Rosenberg; M I Nishimura
Journal: J Immunol Date: 1999-07-01 Impact factor: 5.422

5. Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma.

Authors: Mark E Dudley; John R Wunderlich; James C Yang; Richard M Sherry; Suzanne L Topalian; Nicholas P Restifo; Richard E Royal; Udai Kammula; Don E White; Sharon A Mavroukakis; Linda J Rogers; Gerald J Gracia; Stephanie A Jones; David P Mangiameli; Michelle M Pelletier; Juan Gea-Banacloche; Michael R Robinson; David M Berman; Armando C Filie; Andrea Abati; Steven A Rosenberg
Journal: J Clin Oncol Date: 2005-04-01 Impact factor: 44.544

Cancer immunotherapy: in vivo imaging of adoptively transferred T cells in an immunocompetent host.

1. Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells.

2. Transfer of specificity for human immunodeficiency virus type 1 into primary human T lymphocytes by introduction of T-cell receptor genes.

3. Transfer of specificity by murine alpha and beta T-cell receptor genes.

4. Efficient transfer of a tumor antigen-reactive TCR to human peripheral blood lymphocytes confers anti-tumor reactivity.

5. Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma.

6. A critical role of T cell antigen receptor-transduced MHC class I-restricted helper T cells in tumor protection.

7. Immunotherapy through TCR gene transfer.

8. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.

9. Protection against a nonimmunogenic mouse leukemia by an immunogenic variant obtained by mutagenesis.

10. Cancer immunotherapy: moving beyond current vaccines.

1. Longitudinal imaging of T cell-based immunotherapy with multi-spectral, multi-scale optoacoustic tomography.